Back to ACHN Stock Lookup

ACHN Related Analyst Ratings

Jan 3, 2013 04:40 PM Baird Starts Achillion Pharmaceuticals (ACHN) at Outperform

Nov 12, 2012 12:00 PM Achillion Pharmaceuticals (ACHN) Weakness is a Buying Chance - Analyst

Oct 16, 2012 12:23 PM Deutsche Bank Lifts Target on Achillion Pharmaceuticals (ACHN), Sees 60% Upside

Sep 19, 2012 07:40 AM Size of Hepatitis C Treatment Market Points to Upside for Shares of Gilead (GILD)

Sep 19, 2012 06:55 AM Deutsche Bank Starts Achillion Pharmaceuticals (ACHN) at Buy, Calls Under-Appreciated

Sep 19, 2012 06:28 AM BofA/Merrill Lynch Upgrades Achillion Pharmaceuticals (ACHN) to Buy

Aug 16, 2012 07:11 AM JMP Securities Upgrades Achillion Pharmaceuticals (ACHN) to Market Outperform

Jun 13, 2012 08:55 AM Maxim Group Starts Achillion Pharmaceuticals (ACHN) at Buy

May 7, 2012 09:04 AM UBS Upgrades Achillion Pharmaceuticals (ACHN) to Neutral

Apr 23, 2012 02:22 PM Baird Maintains an 'Outperform' on Achillion Pharmaceuticals (ACHN); Reassuring Clarification on '1625

Apr 23, 2012 01:21 PM Brean Murray Carret & Co. maintains a 'Buy' on Achillion Pharmaceuticals (ACHN); Removes From N-T Focus List, But Dip Offers Investor Opportunity

Apr 23, 2012 12:27 PM Wells Fargo Maintains an 'Outperform' on Achillion Pharmaceuticals (ACHN); A Few Hiccups, But Expect Positive N-T Data

Apr 23, 2012 08:08 AM JMP Securities Downgrades Achillion Pharmaceuticals (ACHN) to Market Perform

Apr 19, 2012 04:29 PM Baird Reiterates an 'Outperform' on Achillion Pharmaceuticals (ACHN); Buy on Weakness

Apr 19, 2012 03:17 PM Brean Murray Carret & Co. Out In Defense of Achillion Pharmaceuticals (ACHN); Superficial Read-Through

Apr 19, 2012 09:44 AM UBS Upgrades Achillion Pharmaceuticals (ACHN) to Neutral

Apr 17, 2012 07:46 AM Credit Suisse Starts Achillion Pharmaceuticals (ACHN) at Outperform

Apr 12, 2012 10:57 AM UPDATE - UBS Initiates Coverage on Achillion Pharma (ACHN) with a Neutral; All-Oral Combo Already Priced In

Apr 12, 2012 08:18 AM UBS Starts BMRN, RDEA, ARIA at Buy, ITMN, ACHN, HGSI, IRWD at Neutral

Apr 5, 2012 09:36 AM Brean Murray Carret & Co. Maintains a 'Buy' on Achillion Pharmaceuticals (ACHN); Becoming Top Hec C Play

Apr 2, 2012 09:13 AM Brean Murray Adds Achillion (ACHN), Pitney Bowes (PBI), Vivus (VVUS) to 'Focus List'; Removes Gilead (GILD)

Mar 27, 2012 01:08 PM Wedbush Assumes Coverage on Achillion Pharmaceuticals (ACHN) at Outperform; Optimism from Pipeline

Feb 17, 2012 11:58 AM JMP Securities Upgrades Achillion Pharmaceuticals (ACHN) to Market Outperform

Feb 17, 2012 09:13 AM Achillion (ACHN), Vertex (VRTX) Flying On Gilead's (GILD) '7977 Setback

Feb 7, 2012 11:38 AM Achillion (ACHN) Shares Rocked as BofA Cuts to Underperform

Feb 7, 2012 06:55 AM BofA/Merrill Lynch Downgrades Achillion Pharmaceuticals (ACHN) Two-Notches to Underperform

Jan 27, 2012 09:17 AM Idenix Pharmaceuticals (IDIX) Slammed As Shares Slapped with a "Sell"

Jan 10, 2012 02:57 PM Brean Murray Carret Raises Price Target on Achillion Pharmaceuticals (ACHN) Due to ACH-1625 Clinical Profile

Jan 10, 2012 09:19 AM ThinkEquity Doubles Price Target on Achillion (ACHN) to $20

Jan 9, 2012 03:24 PM JMP Cuts Idenix (IDIX) to Market Underperform, Sets $4 Price Target

Jan 9, 2012 10:36 AM Wall Street Hot and Bothered About Idenix (IDIX) and Achillion (ACHN) After INHX/BMY Deal

Dec 15, 2011 11:41 AM Biotech M&A Will Be In Focus in 2012 - Goldman

Dec 5, 2011 01:23 PM Roth Adds Achillion Pharma (ACHN) to 'Focus List'

Nov 29, 2011 03:55 PM Shares of Achillion Pharmaceuticals (ACHN) Continue Higher Into The Close

Nov 28, 2011 04:38 PM Wells Fargo Starts Achillion Pharmaceuticals (ACHN) at Outperform; PI '1625, Though Early, has Best-in-Class Potential

Nov 21, 2011 11:01 AM Baird Maintains an 'Outperform' on Pharmasset (VRUS); First Impression: Positive for Both Companies and the Space

Oct 18, 2011 08:16 AM Wedbush Downgrades Anadys Pharmaceuticals (ANDS) to Neutral; Announces Acquisition by Roche; Additional Takeover Targets Remain

Oct 17, 2011 01:05 PM Piper Jaffray Call Achillion (ACHN) a M&A Play Following Roche Buyout of Anadys

Sep 8, 2011 07:37 AM Piper Jaffray Starts Achillion Pharmaceuticals (ACHN) at Overweight

Aug 25, 2011 07:25 AM Baird Starts Achillion Pharmaceuticals (ACHN) at Outperform; Pure Play in a HCV Sweet Spot

Jul 26, 2011 07:34 AM Wedbush Assumes Achillion Pharmaceuticals (ACHN) at Outperform; Diverse and Differentiated Pipeline

Jun 2, 2011 09:59 AM Brean Murray Carret & Co. Starts Achillion Pharmaceuticals (ACHN) at Buy, $9 Pirce Target

Jun 2, 2011 08:45 AM ThinkEquity Starts Achillion Pharmaceuticals (ACHN) at Buy

May 26, 2011 07:56 AM William Blair Starts Achillion Pharmaceuticals (ACHN) at Outperform

May 12, 2011 10:14 AM Roth Capital Starts Achillion Pharmaceuticals (ACHN) at Buy

Feb 28, 2011 05:07 PM Leerink Swann Starts Achillion Pharmaceuticals (ACHN) at Outperform; Attractive Emerging HCV Portfolio

Feb 4, 2011 07:32 AM BofA/Merrill Lynch Starts Achillion Pharmaceuticals (ACHN) at Buy

Jul 12, 2010 12:14 PM Leerink Swann Says M&A Is One Reason To Get Involved In Biophama (AGN, DNDN, BMRN, HGSI, more...)

Feb 2, 2010 08:45 AM Wedbush Upgrades Achillion Pharmaceuticals (ACHN) to Outperform

Dec 23, 2009 09:35 AM Roth Initiates Coverage on Achillion Pharmaceuticals (ACHN) with a Buy

Back to ACHN Stock Lookup